JGGDR
JGP Global Gestao de Recursos Portfolio holdings
AUM
$204M
This Quarter Return
+8.63%
1 Year Return
+109.69%
3 Year Return
+285.93%
5 Year Return
+345.7%
10 Year Return
+378.07%
AUM
$79.6M
AUM Growth
+$79.6M
(+571%)
Cap. Flow
+$67.9M
Cap. Flow
% of AUM
85.24%
Top 10 Holdings %
Top 10 Hldgs %
87.6%
Holding
35
New
19
Increased
1
Reduced
2
Closed
8
Top Buys
| 1 |
Galicia Financial Group
GGAL
|
$15.8M |
| 2 |
iShares MSCI Brazil ETF
EWZ
|
$10.4M |
| 3 |
Kraft Heinz
KHC
|
$9.48M |
| 4 |
Mercado Libre
MELI
|
$9.17M |
| 5 |
NGD
New Gold Inc
NGD
|
$8.16M |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
$1.47M |
| 2 |
UnitedHealth
UNH
|
$1.46M |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$1.31M |
| 4 |
Eli Lilly
LLY
|
$529K |
| 5 |
Regeneron Pharmaceuticals
REGN
|
$472K |
Sector Composition
| 1 | Financials | 22.97% |
| 2 | Materials | 22.56% |
| 3 | Consumer Discretionary | 13.71% |
| 4 | Consumer Staples | 11.91% |
| 5 | Healthcare | 11.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Galicia Financial Group
GGAL
$6.31B
| $15.8M | 16.26% |
+307,314
| New | +$15.8M |
|
|
2
iShares MSCI Brazil ETF
EWZ
$5.45B
| $10.4M | 10.7% |
+250,000
| New | +$10.4M |
|
|
3
Kraft Heinz
KHC
$33.1B
| $9.48M | 9.73% |
+122,292
| New | +$9.48M |
|
|
4
Mercado Libre
MELI
$125B
| $9.17M | 9.41% |
+35,400
| New | +$9.17M |
|
|
NGD
5
New Gold Inc
NGD
$4.67B
| $8.16M | 8.38% |
+2,200,000
| New | +$8.16M |
|
6
Vale
VALE
$43.9B
| $5.75M | 5.9% |
+570,760
| New | +$5.75M |
|
7
Alamos Gold
AGI
$12.8B
| $4.06M | 4.16% |
+600,000
| New | +$4.06M |
|
8
Incyte
INCY
$16.5B
| $2.68M | 2.75% |
22,938
-362
| -2% | -$42.3K |
|
9
Banco Macro
BMA
$3.7B
| $2.45M | 2.52% |
+20,900
| New | +$2.45M |
|
|
NETS
10
DELISTED
Netshoes (Cayman) Limited
NETS
| $1.75M | 1.79% |
+133,000
| New | +$1.75M |
|
11
BioMarin Pharmaceuticals
BMRN
$11.2B
| $1.72M | 1.77% |
18,506
-758
| -4% | -$70.5K |
|
|
AZUL
12
DELISTED
Azul
AZUL
| $1.51M | 1.55% |
+54,900
| New | +$1.51M |
|
|
SGEN
13
DELISTED
Seagen Inc. Common Stock
SGEN
| $1.12M | 1.15% |
20,603
+969
| +5% | +$52.7K |
|
|
AERI
14
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $673K | 0.69% |
+13,844
| New | +$673K |
|
15
Bristol-Myers Squibb
BMY
$96B
| $659K | 0.68% |
+10,340
| New | +$659K |
|
16
Amicus Therapeutics
FOLD
$2.34B
| $570K | 0.59% |
+37,773
| New | +$570K |
|
17
Exelixis
EXEL
$10.1B
| $534K | 0.55% |
+22,020
| New | +$534K |
|
18
Assembly Biosciences
ASMB
$190M
| $510K | 0.52% |
+14,596
| New | +$510K |
|
19
Boston Scientific
BSX
$156B
| $446K | 0.46% |
+15,302
| New | +$446K |
|
20
Acadia Pharmaceuticals
ACAD
$4.38B
| $437K | 0.45% |
+11,607
| New | +$437K |
|
|
EPZM
21
DELISTED
Epizyme, Inc
EPZM
| $292K | 0.3% |
+15,333
| New | +$292K |
|
22
iShares MSCI Emerging Markets ETF
EEM
$19B
| – | – |
0
| – | – |
|
23
VanEck Gold Miners ETF
GDX
$19B
| – | – |
0
| – | – |
|
|
24
Eli Lilly
LLY
$657B
| – | – |
-6,426
| Closed | -$529K |
|
25
Neurocrine Biosciences
NBIX
$13.8B
| – | – |
-5,890
| Closed | -$271K |
|